"10.1371_journal.pone.0072138","plos one","2013-08-19T00:00:00Z","Jean-Christophe Simard; Annabelle Cesaro; Julie Chapeton-Montes; Mélanie Tardif; Francis Antoine; Denis Girard; Philippe A Tessier","Laboratoire de Recherche en Inflammation des Granulocytes, Université du Québec Institut National de la Recherche Scientifique, Institut Armand-Frappier, Laval, Québec, Canada; Axe Maladies Infectieuses et Immunitaires, Centre de Recherche du CHU de Québec and Faculté de Médecine, Université Laval, Québec, Canada","Conceived and designed the experiments: JCS AC JCM MT FA DG PAT. Performed the experiments: JCS AC JCM MT FA DG PAT. Analyzed the data: JCS AC JCM MT FA DG PAT. Wrote the paper: JCS AC JCM MT FA DG PAT.","The authors have read the journal’s policy and have the following conflicts. This manuscript is related to the following patents: 1. P.A. Tessier, K. Vandal, P. Rouleau C. Ryckman, CHEMOTACTIC FACTOR INHIBITOR FOR MODULATING INFLAMMATORY REACTIONS, European Patent Application EP1519749, filing date 20/06/2003, publication date 06/04/2005, granted 06/03/2009, Licensed to InflammatoRx inc. 2. P.A. Tessier, K. Vandal, P. Rouleau C. Ryckman, ANTIBODIES AGAINST S100A8 AND S100A9 PROTEINS FOR MODULATING INFLAMMATORY REACTIONS, US7,553,488, filing date 15/07/2005, publication date 29/12/2005, granted 30/06/2009, Licensed to InflammatoRx inc. This does not alter the authors’ adherence to all the PLOS ONE policies of sharing data and materials.","2013","08","Jean-Christophe Simard","JCS",7,TRUE,7,7,7,7,TRUE,TRUE,FALSE,0,NA,FALSE
